| Primary |
| Drug Use For Unknown Indication |
31.0% |
| Drug Therapy |
13.8% |
| Blood Pressure Management |
10.3% |
| Hypotension |
10.3% |
| Vasoconstriction |
10.3% |
| Haemodynamic Instability |
6.9% |
| Intentional Overdose |
3.4% |
| Medication Error |
3.4% |
| Product Used For Unknown Indication |
3.4% |
| Resuscitation |
3.4% |
| Vasopressive Therapy |
3.4% |
|
| Hypoglycaemia |
16.7% |
| Medication Error |
12.5% |
| Hypotension |
8.3% |
| Pulse Absent |
8.3% |
| Tachycardia |
8.3% |
| Circumstance Or Information Capable Of Leading To Medication Error |
4.2% |
| Drug Dose Omission |
4.2% |
| Extravasation |
4.2% |
| Intestinal Ischaemia |
4.2% |
| Liver Injury |
4.2% |
| Skin Necrosis |
4.2% |
| Therapeutic Response Decreased |
4.2% |
| Treatment Failure |
4.2% |
| Type Iv Hypersensitivity Reaction |
4.2% |
| Ventricular Fibrillation |
4.2% |
| Wrong Drug Administered |
4.2% |
|
| Secondary |
| Product Used For Unknown Indication |
15.9% |
| Pneumonia |
13.9% |
| Cardiac Failure |
8.4% |
| Drug Therapy |
8.4% |
| Prophylaxis |
7.2% |
| Nutritional Support |
6.0% |
| Depression |
4.0% |
| Infection |
3.6% |
| Pain |
3.6% |
| Acute Myocardial Infarction |
3.2% |
| General Anaesthesia |
3.2% |
| Intraoperative Care |
3.2% |
| Pneumonia Bacterial |
3.2% |
| Sedation |
2.8% |
| Anxiety |
2.4% |
| Disseminated Tuberculosis |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Maternal Exposure During Pregnancy |
2.4% |
| Disseminated Intravascular Coagulation |
2.0% |
| Drug Exposure During Pregnancy |
2.0% |
|
| Sepsis |
12.1% |
| Allergic Myocarditis |
9.1% |
| Thermal Burn |
9.1% |
| Hypernatraemia |
6.1% |
| Platelet Count Decreased |
6.1% |
| Pulseless Electrical Activity |
6.1% |
| Thirst |
6.1% |
| Toxic Epidermal Necrolysis |
6.1% |
| Vision Blurred |
6.1% |
| Altered State Of Consciousness |
3.0% |
| Ascites |
3.0% |
| Circumstance Or Information Capable Of Leading To Medication Error |
3.0% |
| Constipation |
3.0% |
| Foetal Heart Rate Disorder |
3.0% |
| Loss Of Consciousness |
3.0% |
| Obstructive Airways Disorder |
3.0% |
| Off Label Use |
3.0% |
| Premature Baby |
3.0% |
| Pulse Absent |
3.0% |
| Stevens-johnson Syndrome |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.8% |
| Prophylaxis |
14.4% |
| Drug Use For Unknown Indication |
11.6% |
| Premedication |
4.5% |
| Cardiac Failure |
3.6% |
| Infection Prophylaxis |
3.1% |
| Sepsis |
2.9% |
| Acute Myocardial Infarction |
2.8% |
| Pain |
2.3% |
| Bone Marrow Conditioning Regimen |
2.2% |
| General Anaesthesia |
2.2% |
| Hypertension |
2.0% |
| Pneumonia |
1.9% |
| Disseminated Intravascular Coagulation |
1.9% |
| Prophylaxis Against Graft Versus Host Disease |
1.9% |
| Supportive Care |
1.9% |
| Graft Versus Host Disease |
1.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Sedation |
1.8% |
| Anaesthesia |
1.6% |
|
| Thrombocytopenia |
9.9% |
| Renal Failure Acute |
9.4% |
| Multi-organ Failure |
8.0% |
| Ventricular Tachycardia |
7.5% |
| Sepsis |
6.6% |
| Vomiting |
6.6% |
| Renal Failure |
5.7% |
| Renal Impairment |
5.2% |
| Respiratory Failure |
4.7% |
| Fungal Infection |
4.2% |
| Urine Output Decreased |
4.2% |
| Cardiac Failure |
3.3% |
| Hypernatraemia |
3.3% |
| Shock |
3.3% |
| Staphylococcal Sepsis |
3.3% |
| Ventricular Fibrillation |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| Death |
2.8% |
| White Blood Cell Count Increased |
2.8% |
| Pneumonia |
2.4% |
|
| Interacting |
|
|
